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 Introduction 
 Synthetic biology is a nascent interdisciplinary research 
field that leverages rational design approaches based on 
engineering principles.  1 , 2  Synthetic biology distinguishes 
itself from traditional genetic engineering in several ways: 
(1) synthetic biology takes advantage of de novo DNA syn-
thesis technologies, rather than relying on the existing natu-
ral templates; (2) synthetic biologists use standardized 
genetic parts not only to facilitate the assembly of novel 
sequences, but also to more predictably construct the bio-
logical system based on the characterization of individual 
parts  3  ; and (3) similar to other engineering disciplines, com-
puter-assisted designers (CADs) and mathematical model-
ing are instrumental in synthetic biology to effectively help 
synthetic biologists navigate the design space.  4  
 Although synthetic biology is still in an early stage, several 
breakthroughs in the past decade have already demonstrated its 
great potential for society; for instance, Keasling’s group used 
a synthetic biology approach to engineer the baker’s yeast 
Saccharomyces cerevisiae to produce artemisinin, an impor-
tant antimalarial drug.  5  Lu and Collins engineered bacterio-
phage for an antibiotic therapy  6  and, more recently, also 
developed a paper-based cell-free methodology to rapidly 
detect Ebola viruses.  7  
 The enabling technology for synthetic biology is the 
development of a suite of advanced DNA synthesis and 
assembly methods, such as Golden Gate assembly,  8  Gibson 
assembly,  9  circular polymerase extension cloning (CPEC),  10 
transformation-assisted recombination (TAR) cloning,  11 
and PaperClip assembly  12  (for a comprehensive review on 
DNA assembly methods, refer to Ellis et al.  13  ). Collectively, 
these technologies open up the possibility to redesign and 
resynthesize DNA at the genome scale. Poliovirus cDNA 
was synthesized without a natural template in 2002 by Cello 
et al.  14  Itaya’s group pioneered the combination of two 
genomes in one cell in vivo.  15  The J. Craig Venter Institute 
chemically resynthesized a bacterial genome  16  and devel-
oped the genome transplantation technology to reboot the 
cell with the synthetic bacterial genome.  17  Together with 
several other groups across the world, our group is part of 
the international synthetic yeast consortium ( www.syntheti 
cyeast.org ), which aims to redesign and resynthesize the 
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 Abstract 
 Acoustic droplet ejection (ADE) technology uses focused acoustic energy to transfer nanoliter-scale liquid droplets with 
high precision and accuracy. This noncontact, tipless, low-volume dispensing technology minimizes the possibility of cross-
contamination and potentially reduces the costs of reagents and consumables. To date, acoustic dispensers have mainly 
been used in screening libraries of compounds. In this paper, we describe the first application of this powerful technology 
to the rapidly developing field of synthetic biology, for DNA synthesis and assembly at the nanoliter scale using a Labcyte 
Echo 550 acoustic dispenser. We were able to successfully downscale PCRs and the popular one-pot DNA assembly 
methods, Golden Gate and Gibson assemblies, from the microliter to the nanoliter scale with high assembly efficiency, 
which effectively cut the reagent cost by 20- to 100-fold. We envision that acoustic dispensing will become an instrumental 
technology in synthetic biology, in particular in the era of DNA foundries. 
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world’s first eukaryotic genome. We recently reported the 
completion of the first synthetic yeast chromosome arm18 
and the first fully synthetic eukaryotic chromosome.19 As a 
safety measurement and responsible innovation in synthetic 
biology, efficient biocontainment technologies have been 
developed to restrict the viability of engineered microbes to 
prevent the dual use of synthetic biology technologies.20
Traditional liquid handling technology has enabled 
increased throughput of many Life Sciences (Lowell, MA) 
protocols and assays by (1) increasing operational speeds, (2) 
reducing working volumes (down to a microliter range), and 
(3) reducing the need for a generally error-prone human han-
dling, and ultimately contributed to substantial workflow cost 
savings. Despite an already big “leap forward,” the demand 
for further protocol miniaturization continues to increase, in 
particular in ultra-high-throughput screening (uHTS).21 
Traditional tips/nozzles-based robotic platforms struggle to 
precisely dispense liquid droplets below the microliter thresh-
old. Pin tools can be used to transfer nanoliter to microliter 
liquid from source plates to destination plates; however, 
because they are contact based, the pin tools usually require 
washing and drying between transfers to avoid cross-contam-
ination. Also, the delivery volume of pin tools is difficult to 
control, as it is due to a combination of many factors, such as 
the shape of the pin, the diameter of the pin, the coating of the 
pin, and the speed of dipping and removing of the pin. Finally, 
pin tools are usually made in 96, 384, and 1536 formats, 
which limits their flexibility of usage, e.g., in setting up differ-
ent reaction volumes in the same plate. Another technology 
allowing reaction miniaturization is the microfluidic chip 
technology.22 Kong and others have successfully used micro-
fluidic chips to synthesize DNA sequences up to 1 kb,23 and 
Tewhey et al. used microfluidic chips to run 1.5 million PCRs 
in parallel.24 The main disadvantage of the microfluidic chip 
approach is that the master molds and the control layer need to 
be custom designed and fabricated for different reactions; 
however, the de novo DNA synthesis using microfluidic chips 
is very complementary with the miniaturized assembly meth-
ods described in this paper.
First described in 1927, the acoustic droplet ejection 
(ADE) phenomenon utilizes acoustic energy to rapidly 
move low-volume nanoliter to picoliter droplets without 
any physical contact.25 Before it reached the laboratory set-
ting in the 2000s, the drop-on-demand technology was first 
exploited in a number of other fields, including the ink-jet 
printing industry. Today, Labcyte, Inc. (Sunnyvale, CA) is 
pioneering the acoustic dispensing technology for Life 
Sciences, with its Echo series robotic platforms being able 
to transfer multiple 2.5 or 25 nL droplets from the 384- and 
1536-well sources to the various (inverted) destination 
plates. Unlike traditional robotic liquid transfer methods, 
laboratory acoustic dispensing has been shown to be highly 
precise at the nanoliter volume range (as demonstrated by 
its low coefficients of variation), therefore enabling the 
desired further miniaturization of current protocols and 
assays. The acoustic dispenser is flexible enough to set up 
any-to-any configurations between the source plate and the 
destination plate, and the reaction volumes can vary from 
well to well in the same reaction plate.
Here, for the first time, we report yet another exciting 
acoustic dispensing application: nanoliter-scale DNA assem-
bly. The majority of assembly expenses are enzymes, includ-
ing DNA polymerases, Therefore, downscaling the reaction 
volume from the microliter to the nanoliter scale while main-
taining high assembly efficiency, will make DNA synthesis 
and assembly more accessible to synthetic biologists.
Materials and Methods
Echo PCR
Conventional endpoint PCR is instrumental in making syn-
thetic DNA. To test the minimal volume of regular PCR 
using Echo, we set up PCRs of various volumes. The plas-
mid HcKan_P vector (120 ng/µl) was used as the DNA tem-
plate, and a pair of primers YCp2214 and YCp2215 were 
designed to amplify a targeted DNA fragment of 1378 bp 
(Fig. 1A; all primers used in this paper are listed in Suppl. 
Table S1). The GoTaq Green Master Mix (Promega, 
Madison, WI) was used in the PCR. Five reaction volumes 
ranging from 50 to 1000 nL were set up (Table 1), and each 
reaction was performed in four replicates. All PCRs were 
set up using the following cycling conditions: preheat the 
PCR machine and then put in the PCR plate, 2 min at 95 °C, 
32 cycles of 10 s at 95 °C, 30 s at 50 °C and 2 min at 72 °C, 
7 min at 72 °C, and hold at 4° C. GoTaq Green Master Mix 
(35 µL) and double-distilled water (ddH2O; 30 µL) were 
added separately to source plate 1, which was an Echo 384-
well polypropylene plate (Labcyte). YCp2214 and YCp2215 
(10 µL each) and template DNA (10 µL) were added sepa-
rately to source plate 2, which was an Echo 384-well low-
dead-volume plate (Labcyte). The destination plate used in 
this paper was MicroAmp EnduraPlate (Life Technologies, 
Carlsbad, CA).
Gibson DNA Assembly
First described in 2009, the Gibson DNA assembly method9 
belongs to a group of overlap-directed DNA assembly tech-
niques such as CPEC,10 SLiCE,26 and SLIC27 assemblies. The 
Gibson assembly method is one of the most used in synthetic 
biology, and it can assemble DNA sequences up to small 
genome sizes from overlapping DNA fragments in an isother-
mal one-pot reaction. The advantage of Gibson assembly is 
that it is sequence independent and generates scarless final 
assembled DNA products. Typically, the Gibson assembly 
requires about a 40 bp homologous region between two adja-
cent DNA fragments, and these homologous regions are usu-
ally added to the fragments by a high-fidelity PCR. Briefly, the 
assembly reaction takes place in a cocktail of enzymes (termed 
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Gibson master mix) at 50 °C for 60 min: (1) First, T5 exonu-
lease chews back the DNA in a 5′ to 3′ direction from the 
homologous terminal ends to reveal reverse complementary 
single-stranded sequences between two adjacent fragments. 
(2) While the 5′ to 3′ DNA digestion proceeds, a high-fidelity 
DNA polymerase fills in the single-stranded DNA region. (3) 
Finally, Taq DNA ligase seals the nicked DNA strands, which 
yields the final assembled product.
Gibson Reaction Setup by Echo. Two pairs of primers 
(YCp2391 and YCp2392 for fragment 1, YCp2393 and 
YCp2394 for fragment 2) were designed to amplify two frag-
ments with 40 bp end homology from a red fluorescent pro-
tein (RFP)–containing plasmid pPC025, thus allowing 
subsequent Gibson reassembly of the plasmid. The two 
homologous junctions were placed within the ampicillin 
resistance gene and the RFP open reading frame (ORF) to 
reduce the overall false positive rate and to allow phenotypic 
screening for successful assembly isolates, respectively. In 
contrast to Golden Gate assembly (see below), here RFP 
serves as a positive screen for correct assemblies. PCR prod-
ucts were gel purified using the QIAquick gel extraction kit 
(Qiagen, Valencia, CA). The standard 15 µL Gibson assem-
bly master mix was prepared as described in the original Gib-
son assembly paper.9 Gibson master mix (40 µL) was added 
to source plate 1, which is an Echo 384 polypropylene plate 
(Labcyte). Each DNA fragment (10 µL) was added to source 
plate 2, which is an Echo 384 low-dead-volume plate (Lab-
cyte). One-pot Gibson assembly was incubated at 50 °C for 
60 min in a preheated PCR thermal cycler (Table 2).
Golden Gate Assembly
The Golden Gate DNA assembly method utilizes a combina-
tion of a TypeIIS restriction enzyme and a ligase to assemble 
the DNA fragments.8 TypeIIS enzymes (e.g., BsaI and BsmBI 
enzymes) are endonucleases that cut outside their recognition 
sites, creating 4 bp DNA overhangs. By carefully designing 
the 4 bp overhangs, one can use the Golden Gate reaction to 
directionally assemble DNA fragments. The Golden Gate 
DNA assembly reaction starts with a given TypeIIS endonu-
clease DNA digestion, leaving behind staggered cuts in the 
backbone and the fragment DNA. The design-imposed DNA 
complementarity allows annealing of the resulting “sticky 
ends,” creating the desired plasmid construct. In the final 
reaction step, the T4 DNA ligase repairs the nicks to com-
plete the DNA construction phase.
Golden Gate Reaction Setup by Echo. The HcKan_P plasmid 
(2.8 kb, diluted to 10 ng/µl) was used as the acceptor vector. 
This plasmid carries a KanR selectable marker, along with 
a RFP cassette flanked by a pair of outward-facing BsaI 
Table 1. PCR Setup.
Reagent/nl Echo Echo Echo Echo Echo Manual
Primer YCp2214 2.5 12.5 25.0 37.5 50.0 500.0
Primer YCp2215 2.5 12.5 25.0 37.5 50.0 500.0
Template DNA 5.0 25.0 50.0 75.0 100.0 1000.0
ddH2O 15.0 75.0 150.0 225.0 300.0 3000.0
GoTaq Green Master Mix 25.0 125.0 250.0 375.0 500.0 5000.0
Total 50 nL 250 nL 500 nL 750 nL 1000 nL 10,000 nL
Figure 1. PCR setup by Echo.  
(A) A pair of primers was designed 
to amplify a fragment of 1.3 kb, and 
PCRs of various volumes were set 
up by the Echo machine. (B) Gel 
electrophoresis confirms that PCR 
can work at the 250 nL scale.
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sites. We amplified the promoter pMBP1 (500 bp) directly 
from yeast BY4741 (MATa, leu2∆0 met15∆0 ura3∆0 
his3∆1) genomic DNA with primers YCp2395 and 
YCp2396 and added a pair of inward-facing BsaI sites to 
flank the promoter part (Fig. 2A). The PCR product was 
purified using a PureLink PCR purification kit (Life Tech-
nologies) and diluted to 20 ng/µl. The 4 bp overhangs were 
designed in such a way that the promoter can be efficiently 
assembled into the acceptor vector. Bacteria carrying the 
residual RFP plasmid will give a bright red pigment, which 
would facilitate the visual identification of correct assem-
bled clones (white colonies; see Fig. 2C).
The Golden Gate master mix was made of 35 µL T4 
ligase (2000 U/µl, New England Biolabs, NEB), 35 µL 
BsaI-HF (NEB), 52.5 µL 10× T4 buffer (NEB), and 25 µL 
200× BSA (NEB). Golden Gate assembly reactions were set 
up using the following cycling conditions: 15 cycles of 5 
min at 37 °C and 10 min at 16 °C, 5 min at 50 °C, 10 min at 
80 °C, and hold at 4 °C. Five reaction volumes arranging from 
50 to 1000 nL were set up (Table 3), and each reaction was 
performed in triplicate. A manual positive control reaction 
of 7.5 µL was also set up to confirm the fidelity of the 
reagents. Golden Gate master mix (30 µL) was added to 
source plate 1, which is an Echo 384 polypropylene plate 
(Labcyte). pMBP1 PCR product (10 µL) and HcKan_P vec-
tor (10 µL) were added to source plate 2, which is an Echo 
384 low-dead-volume plate (Labcyte).
Bacterial Transformation
As the assembly reactions set up by Echo were at the nanoli-
ter scale, it is difficult to take out the assembled DNA using 
pipets and transform them into bacterial competent cells. 
Instead, bacterial competent cells were added to each well 
containing an assembled product. Competent Escherichia 
coli (20 µL; MAX Efficiency DH5α, Life Technologies) was 
added to each well of the reaction plate. The PCR plate was 
incubated on ice for 20 min and then placed in a heat block at 
42 °C for 45 s. The plate was placed back on ice to incubate 
for 5 min, before adding 200 µL of room temperate super 
Optimal Catabolite repression (SOC) medium to each well. 
The plate was incubated at 37 °C with shaking at 200 rpm for 
1 h. A multichannel pipet was used to slowly drip 40 µL of 
each transformation mixture onto an omnitray containing 
selective solid agar medium (LB—Kan). Alternatively, 100 
µL of transformation mixture was plated on individual petri 
dishes with selective solid agar medium (Golden Gate assem-
bly, LB—Kan; Gibson assembly, LB—Amp). Plates were 
incubated overnight at 37 °C until single colonies appeared.
Gel Electrophoresis
Gel electrophoresis was performed to analyze the PCR 
products (120 V, 30 min; 1% w/v agarose in Tris-acetate-
EDTA (TAE) buffer with 1× SYBR Safe DNA stain). Each 
PCR product was first diluted with ddH2O to a final volume 
of 5 µL when the PCR volume was smaller than 5 µL.
Sanger Sequencing
A BigDye Terminator v3.1 Cycle Sequencing Kit (Life 
Technologies) was used to verify the DNA assembly clones 
according to the manufacturer’s instructions, and the Sanger 
sequencing reactions were carried out by Edinburgh 
Genomics.
Results and Discussion
We used the Echo machine to set up PCRs in total volumes 
ranging from 50 nL to 1 µL (Fig. 1 and Table 1). Starting 
from 250 nL, a band of the correct size could be detected in 
the gel electrophoresis. Because we diluted the PCR prod-
uct to 5 µL in order to run the gel electrophoresis, it is pos-
sible that PCRs at 50 nL scale were successful, but the gel 
electrophoresis was not sensitive enough to detect the sig-
nal. Alternatively, it would be possible to use the Caliper 
Labchip GX instrument that can detect DNA concentrations 
as low as 5 ng/µL. Downsizing the PCR from 50 µL or 
higher to 250 nL already effectively cuts the reagent cost by 
200-fold. Miniaturized PCR is ideal for diagnostic purposes 
such as fast genotyping and colony-screening PCR, but it is 
less suitable for applications requiring use of the PCR prod-
uct for downstream procedures, such as cloning, because 
the yield of double-stranded DNA may not be sufficient.
Gibson assembly worked extremely well in this experi-
ment. Correct assembly was observed from as low as the 
250 nL reaction volumes, and at 500 and 1000 nL the 
assembly efficiencies are comparable with or better than the 
manual control of the 20 µL reaction, but with a significant 
standard deviation. This allows us to cut the reagent cost by 
20-fold or more. Even more encouraging, we observed no 
background (Fig. 2C) and 100% correct assembly through 
Table 2. Gibson Assembly Reactions.
Reagent/nl Echo Echo Echo Echo Manual
Gibson master mix 37.5 187.5 375.0 750.0 15,000.0
Fragment 1 (113.8 ng/µl) 5.0 20.0 40.0 80.0 2,500.0
Fragment 2 (86.8 ng/µl) 7.5 42.5 85.0 170.0 2,500.0
Total 50 nL 250 nL 500 nL 1000 nL 20,000 nL
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Figure 2. Gibson assembly reaction setup by Echo. (A) The pPC025 plasmid was split into two overlapping fragments at the 
middle of the ampicillin resistance gene and the RFP ORF. Two fragments were generated with 40 bp overlap at both ends and then 
assembled by the Gibson assembly reaction. (B) Gel electrophoresis confirming the successful PCR amplification of both fragments. 
(C) Successful Gibson assembly product gives rise to red bacterial colonies. The assembly efficiency was so high that no background 
colonies (white) were observed. Negative control reactions, which had only one fragment in the reactions, yielded no colonies.  
(D) Sequencing verification of both assembly junctions shows 100% assembly accuracy. (E) Cost-effectiveness and assembly efficiency 
comparison of different reaction volumes for Gibson assembly.
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Sanger sequencing across the assembly junctions (six red 
colonies were sequenced; Fig. 2D), and this will be highly 
beneficial for future automation plans, as it will greatly 
reduce the colony screening effort.
With Golden Gate assembly, we successfully assembled 
DNA at a 50 nL reaction volume (typically 15 µL reactions 
when performed manually), and at the 250 and 500 nL scales 
the assembly efficiencies are higher than those of the manual 
control. This leads to at least a 30-fold reduction in reagent use 
when performing Golden Gate reactions using Echo. We did 
observe vector background in the assembly (red colonies, as 
shown in Fig. 3C). There are several ways we can overcome 
this problem. First, instead of using RFP for screening, we can 
use the toxic ccdB gene, which cannot give rise to background 
colonies in a nonpermissive transformation host. Second, we 
can add a higher concentration of the BsaI enzyme in the 
Golden Gate master mix to further digest the residual acceptor 
vector. Finally, we may be able to reduce the background by 
extending the BsaI digestion step in the incubation.
With further optimization, it should be possible to down-
size the reaction volume even further. For instance, in this 
paper, individual components were shot off to the destination 
well one by one (in the case of 50 nL PCRs, only 1 droplet of 
primer was shot), and it is possible that some components 
were not sent into the reaction pool due to slight misalign-
ment of the acoustic dispenser, meaning the reactants simply 
didn’t mix. In this case, it would be of advantage to premix as 
many components as possible and then shoot more droplets 
altogether. We also suggest dispensing the master mix using 
a bulk dispenser or liquid handler, so that the destination well 
has a larger liquid surface to uptake the incoming droplet and 
minimize chances for the droplets hitting the well wall. It is 
always a good practice to centrifuge the PCR plate when 
appropriate before putting it into the PCR thermal cycler to 
start the reaction. To prevent the nanoliter droplet from evap-
orating before the chemical reaction starts, we always preheat 
the PCR machine before putting in the reaction plate. Finally, 
it is more economical to use low-dead-volume plates as the 
source plate for expensive reagents such as enzymes and 
polymerases.
In the world of laboratory automation, efficiency and 
robustness are as important as cost saving. With this in 
mind, we overlaid the number of correct assemblies (effi-
ciency) with standard deviation (robustness) in the same 
plot with the cost of reactions for the Gibson assembly (Fig. 
2E) and the Golden Gate assembly (Fig. 3E). The intersec-
tions of the two curves indicate the “sweet spots” for choos-
ing desired reaction volumes, which are of high efficiency, 
low standard deviation, and relatively low cost. It should be 
noted that our cost calculation did not take into account the 
dead volume of reagents, and logically it can be assumed 
that the dead-volume cost per reaction would decrease as 
more reactions are set up by Echo in one experiment. 
Whenever possible, low-dead-volume plates should be used 
for expensive reagents to save cost. Conversely, we did not 
include the tip cost in the manual control experiments, 
which increase substantially when the number of reactions 
is scaled up. Continuously monitoring DNA assembly effi-
ciency along with the assembly cost is critical to successful 
operation of a large DNA synthesis and assembly automa-
tion facility, such as the UK DNA foundries.
The acoustic dispensing has great potential in automat-
ing other molecular biology operations. We also used the 
Echo to purify single colonies from bacterial and yeast 
cultures, which is traditionally challenging to automate. 
As Echo is capable of dispensing nanoliter droplets with 
high precision, it is also ideal for generating high-density 
assembly libraries through combinatorial assembly meth-
ods. In conclusion, the work described here is the first 
report on use of the acoustic dispenser in the area of syn-
thetic biology, and we envision that this technology will 
be instrumental in lab automation, in particular in the era 
of DNA foundries.
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